Impaired Glucose Tolerance Completed Phase 3 Trials for Rosiglitazone (DB00412)

Also known as: Prediabetic State (IGT) / Impaired Glucose Tolerance (IGT) / IGT - Impaired Glucose Tolerance / Glucose tolerance impaired / Impaired Glucose Tolerance (Prediabetes) / Pre-diabetic State / Prediabetic State / Pre-Diabetic / Pre Diabetes / Pre-Diabetes / Pre Diabetic / Prediabetes / Prediabetic / Latent diabetes / Chemical diabetes / Glucose intolerance / Malabsorption of glucose (disorder) / Impaired glucose tolerance (disorder) / Prediabetes (finding) / Borderline diabetes

IndicationStatusPhase
DBCOND0030184 (Impaired Glucose Tolerance)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00489229To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT PatientsTreatment
NCT00140647The Study of Atherosclerosis With Ramipril and RosiglitazonePrevention
NCT00116922A Lifestyle and Combination Medication Therapy Diabetes Prevention StudyPrevention
NCT00095654The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) TrialPrevention
NCT01574820Role of Rosiglitazone on Pre-Diabetes Mellitus and Coronary Artery DiseaseTreatment